The SDHA gene amplification is highly prevalent in ovarian cancer, and has been reported in a considerably higher frequency in ovarian tumors than in many other malignancies (TCGA data) indicating its potential role in reprogramming of ovarian cancer metabolism. This evidence concerns the gene SDHA and ovarian neoplasm.